The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Share News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.53
Bid: 1.53
Ask: 1.60
Change: -0.002 (-0.13%)
Spread: 0.07 (4.575%)
Open: 1.53
High: 1.53
Low: 1.53
Prev. Close: 1.567
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: Codemasters On Up As Finds Right Formula

Tue, 11th Aug 2020 12:36

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Codemasters Group Holdings PLC - Warwickshire-based video game developer - Revenue and adjusted earnings before interest, tax, depreciation and amortisation will be "significantly" ahead of market expectations in year to March 31, 2021. Codemasters notes strong performance from F1 2020 game, latest instalment of Formula One games.

----------

Parity Group PLC - London-based recruitment and professional services firm - Signs partnership agreement with CyberGym to offer cyber-warfare preparedness training. The due win a place on the NI.CO Cyber Security Training Services Framework to provide consultancy and recruitment support in Northern Ireland.

----------

Actual Experience PLC - Bath-headquartered analytics-as-a-service firm - Lands agreement with Verizon Communications Inc to supply its Human Experience Management service to increase employee productivity. Service can spot when digital applications are unresponsive and slow and can identify where improvements can be made.

----------

Solid State PLC - Worcestershire-based computing products manufacturer - Trading in first four months of financial year running to March 31, 2021 ahead of internal expectations. Revenue down 4% annually. Notes all manufacturing sites open again.

----------

Blue Star Capital PLC - esports and payments technology-focused investor - Investee Dynasty eSports Pte Ltd raises SGD3.1 million, about GBP1.7 million, to develop eSports Portal Management platform.

----------

Pires Investments PLC - London-based technology-focused investment firm - Investee Getvisibility signs public sector distribution deal with immixGroup, supplier of enterprise IT services to US public sector.

----------

Two Shields Investments PLC - investor in technology sector - BrandShield cyber protection investee sees new business in first half of 2020 alone equal all of 2019 as Covid-19 boosts demand. Has 11% stake in BrandShield. Also notes announcement by Power Metal Resources PLC - an exploration and development company - on Kalahari Key Mineral Exploration Ltd. KKME, targeting a nickel sulphide prospects in Botswana, is moving closer to drilling and is working with regulators to secure approval of an environmental plan. Power Metal holds just over an 18% stake in KKME, Two Shields holding is just shy of 18%.

----------

McKay Securities PLC - real estate investment trust focused on office, industrial and logistics properties - Acquires fully let logistics asset in Bracknell for GBP10.0 million, representing a net initial yield of 5.6%. Combined contracted rent at 1-4 Willoughby Road is GBP594,722 per year.

----------

Urban Logistics REIT PLC - real estate investment trust focused on industrial and logistics properties in UK - Acquires three assets in Colchester, Exeter and Nottingham for GBP36.8 million in total. Also enters into GBP151 million loan facility with Barclays, Santander and Lloyds to replace existing GBP76 million facility, which was due to expire in 2022. New facility has a three-year term with an option to extend by an extra two-years.

----------

Phoenix Spree Deutschland Ltd - investment company focused on Berlin residential real estate - Portfolio value at June 30 up 2.3% to EUR746.7 million from EUR730.2 million at end of December. Impact of Covid-19 on rent collection has been "limited". Says it is likely that Mietendeckel, a rent capping law in Berlin, will be successfully challenged.

----------

Gunsynd PLC - London-based investment firm - Notes investee Eagle Mountain Mining Ltd begins maiden drilling programme at 80%-owned Oracle Ridge copper mine near Tucson, Arizona.

----------

Cadence Minerals PLC - mineral resources investment company - Amapa iron ore project owner DEV Mineracao SA in constructive dialogue with creditors. Settlement with creditors remains the last precondition before Cadence takes 20% stake in project, located in Brazil.

----------

Westmount Energy Ltd - South America-focused energy investor - Notes Monday announcement by Ratio Petroleum Energy Ltd Partnership that Stena Carron drillship arrived at the Tanager-1 wellsite on the Kaieteur Block, offshore Guyana with drilling expected to kick off "imminently". Westmount holds roughly 0.7% stake in Ratio Petroleum and about 5.4% interest in Cataleya Energy Corp. Ratio and Cataleya hold 25% interest each in Kaieteur.

----------

Panther Metals PLC - Australia and Canada-focused minerals explorer - Finds a total of 253 geophysical anomalies from airborne survey of Big Bear gold project in Ontario, Canada. Notes 39 of 253 anomalies designated as "high-priority".

----------

Salt Lake Potash Ltd - Australia-focused miner - Set to raise AUD98.5 million, about GBP54.0 million, from combination of institutional share offer and retail entitlement offer. Raises AUD71 million from issue of 142.1 million shares as part of institutional offer, while AUD27 million retail entitlement offer is expected to close on August 25.

----------

Pure Gold Mining Inc - Canada-focused gold miner - Reports forest fire is currently active in town just south of Red Lake mine, Ontario. Pure Gold has temporarily suspended operations at mine.

----------

Great Western Mining Corp PLC - mineral explorer with projects in US state of Nevada - Produces first ever gold as a company. Although a small amount, Great Western hails the gold produced from RH Group area of its Mineral County area in Nevada as a "significant milestone".

----------

Shefa Gems Ltd - gemstone explorer in northern Israel - Receives ILS330,000, about GBP74,057, and 313,000 shares in major shareholder Shefa Yamim Ltd to settle debt. Shefa Gems has agreed not to sell Shefa Yamim shares in the market for a period of six months, which started July 20.

----------

Conroy Gold & Natural Resources PLC - gold explorer in Ireland and Finland - Raises GBP800,000 in placing and subscription of 3.2 million shares at 25 pence each. Including exercise of warrants announced in July, Conroy has secured over GBP1.0 million to bolster working capital.

----------

OptiBiotix Health PLC - York-based life sciences company - Results from peer-reviewed studies show its probiotic LPLDL reduces cholesterol and blood pressure. One study showed a 37% fall in total cholesterol and a 5.1% decline in blood pressure.

----------

RUA Life Sciences PLC - Ayrshire, Scotland-based medical device business - Hospital orders recovered from Covid-19 lows faster in US than Europe. US orders now at 90% of pre-pandemic levels, Europe at 67%. Notes furloughed staff have returned to work.

----------

Destiny Pharma PLC - clinical stage biotechnology firm - Safety review of phase 2b clinical trial of lead asset XF-73 completed by independent committee. Study can continue without any recommended changes and recruitment on track to be completed by end of 2020.

----------

Sareum Holdings PLC - drug developer focused on small molecule therapeutics to improve cancer and autoimmune treatment - Expects annual loss on ordinary activities to narrow to GBP960,000 from GBP1.5 million.

----------

Hemogenyx Pharmaceuticals PLC - pre-clinical stage biopharmaceutical firm headquartered in London - Enters into research pact with University of Pennsylvania to advance its chimeric antigen receptor T-cells towards clinical trial. CAR T-cells being developed for potential treatment of acute myeloid leukaemia.

----------

Fusion Antibodies PLC - pharmaceutical company based in Belfast - Notes partner Queens University Belfast awarded GBP50,000 in funding to develop new schemes to boost life science research in Northern Ireland.

----------

Cairn Homes PLC - Dublin-based housebuilder - Revenue in six months to June 30 down about 58% to roughly EUR80.6 million from EUR192.4 million a year earlier. New home sales down 47% to 207 from 390. Operating profit expected to fall 79% to about EUR5.6 million from EUR27.3 million.

----------

Modern Water PLC - London-based water supply company - Expects 2019 results to be released by end of month following audit delays.

----------

S & U PLC - Solihull-based lender focused on motor finance and property bridging - Sales at Advantage Finance recover to nearly 80% of normal levels as more car sales outlets reopen. Advantage sales were previously as low as 40% of normal levels. Loan applications at record high at Advantage but transaction levels 25% less than last year due to tightened underwriting. Aspen benefits from housing sector reopening with new transactions in July being above budget.

----------

Appreciate Group PLC - Liverpool-based multi-retailer - Completes sale of Budworth Properties Ltd unit which owns Valley Road, Birkenhead land and buildings for GBP3.2 million.

----------

Walker Greenbank PLC - Buckinghamshire-based interior furnishings firm - Total brand sales, before licensing, discounts and rebates, in six months to July 31 down 28% annually. In UK, its largest market, sales down 31%. In international arm, sales fell 24%. Notes early pain from Covid-19 but gained momentum as half ended.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
25 Apr 2024 12:19

EARNINGS: LSL starts 2024 "strongly"; Focusrite maintains payout

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
29 Feb 2024 14:04

Hemogenyx Pharmaceuticals raises money for leukaemia treatment

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said it has raised GBP3.3 million through a placing.

Read more
16 Feb 2024 11:27

Hemogenyx shares rise on potential for CBR to treat brain diseases

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Friday said research has shown that its proprietary chimeric bait receptor can be delivered into the brain through programmed microglial cells and could be used for the treatment of brain cancers and some neurodegenerative diseases.

Read more
14 Feb 2024 10:14

Hemogenyx says CBR can be used intranasally to treat viral infections

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said its chimeric bait receptor can be delivered intranasally in the form of messenger RNA for the "potential" treatment of airborne viral infections.

Read more
9 Feb 2024 10:00

IN BRIEF: Hemogenyx shares surge as FDA lifts Hemo-Car-T trial hold

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for deadly blood diseases - US Food & Drug Administration has lifted clinical hold on company's investigational new drug application for Hemo-Car-T to treat acute myeloid leukemia. FDA placed therapy on clinical hold in July due to a splicing deficiency during manufacture of the lentivirus used to produce Car-T cells. Hemogenyx in August produced a "detailed plan, supported by laboratory tests" to address FDA's concerns, which was accepted the following month.

Read more
2 Feb 2024 10:44

IN BRIEF: Hemogenyx hails US patent application progress

Hemogenyx Pharmaceuticals PLC - London-based biopharmaceutical company focused on treatments for deadly blood diseases - Celebrates as patent application is allowed by the US Patent & Trademark Office. The patent is for the process of eliminating hematopoietic stem cells or hematopoietic progenitors in a patient using bi-specific antibodies.

Read more
16 Jan 2024 11:13

Hemogenyx Pharmaceuticals sends complete response on HEMO-CAR-T to FDA

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Tuesday said it submitted a complete response to the previously announced clinical hold of the investigational new drug application to the US Food & Drug Administration.

Read more
8 Jan 2024 10:56

Hemogenyx Pharmaceuticals completes process qualification run

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said it completed a process qualification run.

Read more
28 Nov 2023 16:53

TRADING UPDATES: Upland Resources completes technical study at Sarawak

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

Read more
27 Nov 2023 10:52

Hemogenyx shares up as says CBR platform a potential cancer treatment

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Monday said its chimeric based receptor platform could "potentially" be used to treat cancer and viral diseases.

Read more
15 Nov 2023 15:43

Hemogenyx Pharmaceuticals completes lentivirus re-manufacture

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said it has completed the re-manufacturing of an improved lentivirus devoid of splice variants.

Read more
28 Sep 2023 14:24

EARNINGS: Dar Global profit multiplies, Hemogenyx loss widens

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
18 Sep 2023 14:37

TRADING UPDATES: Avingtrans buys Adaptix, TPXimpact sells Questers

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
18 Sep 2023 13:00

Hermogenyx shares soar on new partnership with Prevail Partners

(Sharecast News) - Shares in biopharma group Hemogenyx surged on Monday after the company received a $0.83m investment from Prevail Partners as it continues to work on its planned clinical trial for leukaemia treatment.

Read more
14 Sep 2023 14:31

Hemogenyx Pharma says US FDA accepts Hemo-Car-T clinical hold lift plan

(Alliance News) - Hemogenyx Pharmaceuticals PLC on Thursday said the US Food & Drug Administration has accepted its plan to address concerns which sparked a clinical hold on its chimeric antigen receptor T-cell or Hemo-Car-T therapy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.